Optimizing paediatric HIV care in Kenya: challenges in early infant diagnosis

Peter Cherutich1, Irene Inwani, Ruth Nduati

  • 1National AIDS/STD Control Programme, Ministry of Health, Nairobi, Kenya. pcheru2000@yahoo.com

Insights

Identifying HIV-infected children in Kenya faced significant barriers, including limited testing availability and systemic weaknesses. Urgent training and a standardized approach are needed to improve pediatric HIV diagnosis and care.

Area of Science:

  • Pediatric infectious diseases
  • Public health policy
  • HIV/AIDS management

Background:

  • Kenya aimed to provide antiretroviral treatment (ART) to 50% of eligible individuals by 2005.
  • By July 2005, over 47,000 individuals, including 2,000 children, were receiving ART.
  • A study was initiated to identify barriers in diagnosing HIV in children.

Purpose of the Study:

  • To determine the challenges and barriers in identifying and diagnosing HIV-infected children within the Kenyan healthcare system.
  • To evaluate the existing policies and infrastructure for pediatric HIV diagnosis.

Main Methods:

  • Reviewed government policies related to HIV care.
  • Analyzed the ART register from the Kenya National AIDS Control Programme to identify ART-providing facilities.
  • Assessed diagnostic capabilities and follow-up systems for HIV-exposed and infected children.

Main Results:

  • Only one facility offered universal HIV testing in antenatal clinics; six facilities systematically followed up HIV-exposed children.
  • HIV antibody testing was not widely available for children.
  • Diagnostic HIV polymerase chain reaction (PCR) was limited to research, with constraints in infrastructure, quality control, and staffing.

Conclusions:

  • The policy framework for identifying HIV-infected children was insufficient, focusing narrowly on sick children.
  • Weaknesses were identified in systematic diagnosis using laboratory or clinical algorithms.
  • Health staff training and a standardized approach are crucial for effective identification of HIV-infected children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...